Cite

HARVARD Citation

    Baird, A. et al. (n.d.). 4: DHMEQ a novel therapeutic option for the treatment of inflammatory mediated cisplatin resistant non-small cell lung cancer. Lung cancer. pp. S2-. [Online]. 
  
Back to record